Skip to main content
    B

    BioAge Labs, Inc (BIOA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $5.22
    -0.33 (-5.95%)

    Market Cap: $255.03M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    BioAge Labs, Inc (BIOA) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    BioAge Labs (BIOA) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, BioAge Labs reported EPS of -$0.73, below the -$0.68 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    33%(3/9)
    Avg Surprise
    -98.18%

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.70
    Range-$0.81 - -$0.63
    13 analysts
    Revenue Consensus
    $1.60M
    RangeN/A
    12 analysts
    Reports May 6, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.69
    Range-$0.78 - -$0.58
    4 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.56-22.9%
    60d ago-$0.56-22.9%
    30d ago-$0.56-22.9%
    7d ago-$0.63-9.9%
    Current-$0.69
    Revenue Consensus
    $383.33K
    RangeN/A
    3 analysts

    Next Report

    BIOA has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 9 quarters below that had an estimate, BIOA beat 3 and missed 6. Revenue for the quarter ended Sep 30, 2026 was $298000, down 85.5% from $2.05M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.73-$0.68-$0.69 - -$0.52-7.35%MissN/A81 up, 1 downNov 5, 2026$298000
    Jun 30, 2026-$0.58-$0.65-$0.75 - -$0.54+10.77%BeatN/A71 up, 0 downAug 6, 2026$2.45M
    Mar 31, 2026-$0.52-$0.71-$0.74 - -$0.50+26.76%BeatN/A43 up, 0 downMay 8, 2026$2.77M
    Dec 31, 2025-$0.72-$0.67-$0.76 - -$0.54-7.69%MissN/A50 up, 1 downMar 24, 2026$3.08M
    Sep 30, 2025-$0.56-$0.51-$0.54 - -$0.50-9.80%MissN/A30 up, 3 downNov 6, 2025$2.05M
    Jun 30, 2025-$0.60-$0.38N/A-57.89%MissN/AN/AN/AAug 6, 2025$2.41M
    Mar 31, 2025-$0.36-$0.53N/A+32.08%BeatN/AN/AN/AMay 6, 2025$1.45M
    Dec 31, 2024-$1.00-$0.66N/A-52.67%MissN/AN/AN/AMar 20, 2025N/A
    Sep 30, 2024-$6.70-$0.73N/A-817.81%MissN/AN/AN/ANov 7, 2024N/A
    Jun 30, 2024-$0.60N/AN/AN/AN/AN/AN/AN/ASep 26, 2024N/A
    Last 10 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$1.83N/A
    Jun 30, 2026-$1.10N/A
    Dec 31, 2025-$2.24N/A
    Dec 31, 2024-$8.30N/A

    Frequently Asked Questions About BIOA

    When is BioAge Labs's next earnings date?

    BioAge Labs's next earnings report is expected for Mar 22, 2027.

    Did BIOA beat earnings estimates last quarter?

    No. BioAge Labs reported EPS of -$0.73 for the quarter ended Sep 30, 2026, below the -$0.68 estimate by 7.35%.

    What EPS do analysts expect from BIOA next quarter?

    The consensus EPS estimate for BioAge Labs for the quarter ending Dec 31, 2026 is -$0.70 from 13 analysts, with estimates from -$0.81 to -$0.63.

    How often does BIOA beat earnings estimates?

    BioAge Labs beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -8.23%.